AP Biosciences Inc (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 180.00
+8.00 (4.65%)
Dec 31, 2025, 2:59 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 15.32 billion as of December 31, 2025. Its market cap has increased by 249.09% in one year.
Market Cap
15.32B
Enterprise Value
14.11B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
180.00
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 15.32B, an increase of 200.66%. That is a compound annual growth rate of 56.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.65B |
| Bora Pharmaceuticals Co., LTD. | 60.52B |
| Lin BioScience | 32.84B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 31.06B |